Literature DB >> 17141455

Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.

Jesús Guinea1, Teresa Peláez, Luis Alcalá, Emilio Bouza.   

Abstract

The in vitro activities of amphotericin B, itraconazole, and voriconazole against 283 clinical isolates of Aspergillus fumigatus were studied by comparing the E test method with the reference procedure NCCLS (CLSI) M-38A. The methods were considered to agree when the results of the MICs by E test were within +/-2 dilutions of the MICs obtained by CLSI M-38 A. Agreement of readings at 24, 48, and 72 h of incubation was as follows: amphotericin B: 4.2%, 98%, and 40.6%; itraconazole: 92.5%, 100%, and 89.9%; and voriconazole: 98.9%, 100%, and 99.7%. The correlation between methods to classify the strains as "susceptible" or "resistant" was very good for itraconazole and voriconazole after 48 h of incubation, but 23% of the strains were incorrectly classified by E test for amphotericin B. The E test is an efficacious method for antifungal susceptibility testing in A. fumigatus for itraconazole and voriconazole when the plates are read after 48 h of incubation. The use of the E test to study the activity of amphotericin B should be avoided.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141455     DOI: 10.1016/j.diagmicrobio.2006.09.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  In Vitro Activity of Antifungal Drugs Against Trichophyton rubrum and Trichophyton mentagrophytes spp. by E-Test Method and Non-supplemented Mueller-Hinton Agar Plates.

Authors:  Jari Intra; Cecilia Sarto; Selene Mazzola; Chiara Fania; Natalia Tiberti; Paolo Brambilla
Journal:  Mycopathologia       Date:  2019-07-11       Impact factor: 2.574

2.  In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens.

Authors:  Jesús Guinea; Sandra Recio; Pilar Escribano; Teresa Peláez; Beatriz Gama; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

3.  Evaluating the resistance to posaconazole by E-test and CLSI broth microdilution methodologies of Candida spp. and pathogenic moulds.

Authors:  R Araujo; S Costa-de-Oliveira; I Coutinho; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-04-07       Impact factor: 3.267

4.  Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.

Authors:  Laura Judith Marcos-Zambrano; Pilar Escribano; Cristina Rueda; Óscar Zaragoza; Emilio Bouza; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

5.  The Aspergillus fumigatus farnesyltransferase β-subunit, RamA, mediates growth, virulence, and antifungal susceptibility.

Authors:  Tiffany S Norton; Qusai Al Abdallah; Amy M Hill; Rachel V Lovingood; Jarrod R Fortwendel
Journal:  Virulence       Date:  2017-05-10       Impact factor: 5.882

6.  Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait.

Authors:  Faten Al-Wathiqi; Suhail Ahmad; Ziauddin Khan
Journal:  BMC Infect Dis       Date:  2013-03-06       Impact factor: 3.090

7.  In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.

Authors:  Jesús Guinea; Teresa Peláez; Sandra Recio; Marta Torres-Narbona; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.938

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.